Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.
Taj Pharma Bags USFDA Nod For Colistimethate sodium injection
Indian pharmaceuticals group announced USFDA approval for Co...
(L) +91-22-6666 7777, (F) +91-22-2496 8238
© copyright 2016 India PRwire (http://www.indiaprwire.com)
India PRwire disclai...
Upcoming SlideShare
Loading in …5
×

Taj pharma bags usfda nod for colistimethate sodium injection indian pharmaceuticals group announced usfda approval for colistimethate sodium for injection and inhalation for united states m

84 views

Published on

Taj Pharma committed to the standards of ethics and integrity



We are totally committed to improving the safety and wellbeing of all people who work with us, or come into contact with our operations and products.

Introduction - Business Opportunities with TAJ PHARMACEUTICALS LTD

TAJ PHARMACEUTICALS LTD. (Pharmaceuticals Inc.) is a product-driven pharmaceutical company with diversified expertise. While TPL is relatively new to the export market, it is by no means a new player.

As a wholly owned subsidiary of TAJ PHARMA GROUP.

Our product development and manufacturing capability, teamed with our ability to market products in many global markets, makes TPL an attractive business ally. A key part of our business strategy is to collaborate with partners with complementary skills - "A Win-Win" strategy that strengthens the position of our partners as well as TPL.

TPL has already experienced commercial success penetrating the semi-regulated markets, and looks forward to enhanced growth and future business opportunities through collaboration and strategic alliances.

API Development and Production
Dosage Form Development and Manufacturing
Contract Manufacturing
Sales and Marketing
Marketing Strategies
Licensing

Published in: Health & Medicine
  • I was searching for a way to explain my recently frequent yeast infections and other related conditions stumbled upon your program on the internet. I suffered from chronic mouth thrush (with creamy white lesions on my tongue and inner cheeks). My baby daughter had the same problem in her mouth and your program was the only thing that helped us! I highly recommend your book to anyone who is perceptive about their health, and for those who are tired of being told that it's all in their heads. I feel so rejuvenated and lucky to have found this system. ➤➤ http://ishbv.com/index7/pdf
       Reply 
    Are you sure you want to  Yes  No
    Your message goes here
  • Great book! I'm on the second week and seeing definite improvement on my yeast infection symptoms. I must also note that the texture of my skin became very soft and consistent. I completely agree with many of your arguments in the book especially those about conventional methods for treating Yeast Infection. I wanted to let you know that I feel so fine you have no idea. I am not so tired all the time and I feel very energetic. The rashes on my neck and on the right side of my nose have also cleared up. I wish you all the health and happiness in the world and thanks so much for helping me. I really appreciate your time and efforts to assist me. ■■■ http://ishbv.com/index7/pdf
       Reply 
    Are you sure you want to  Yes  No
    Your message goes here
  • Be the first to like this

Taj pharma bags usfda nod for colistimethate sodium injection indian pharmaceuticals group announced usfda approval for colistimethate sodium for injection and inhalation for united states m

  1. 1. Taj Pharma Bags USFDA Nod For Colistimethate sodium injection Indian pharmaceuticals group announced USFDA approval for Colistimethate sodium for injection and inhalation for United States market. Mumbai, Maharashtra, March 10, 2012 /India PRwire/ -- Taj Pharma Group declared that it has bagged nod from USFDA to sell Colistimethate sodium for injection and inhalation in the United States. Each Injection contains Colistin 1 MIU - 1 Million International Units (1 MIU) Colistimethate Sodium. In an interview with CNBC, Group CEO A.K.Singh said, 'the proposed U.S. launch will be very affordable for US citizens facing specific lung infections, the generics Colistimethate will be available at very reasonable prices benefitting the American hospitals'. The company will sell Colistin 1 MIU is available in vial of 10 ml in Powder for solution for injection, infusion and inhalation. Colistimethate sodium powder for inhalation (Colobreathe) for Pseudomonas aeruginosa lung infection in cystic fibrosis. Inhalation may induce coughing or bronchospasm. Sore throat or mouth has been reported and may be due to Candida albicans infection or hypersensitivity. Skin rash may also indicate hypersensitivity; if this occurs, treatment should be withdrawn. Colistin is contraindicated in patients with known hypersensitivity to colistimethate sodium (colistin) or to polymyxin B and in patients with myasthenia gravis. Colistimethate sodium is a cyclic polypeptide antibiotic derived from Bacillus polymyxa var. colistinus and belongs to the polymyxin group. The polymyxin antibiotics are cationic surface-active agents that work by damaging the cell membrane. The resulting physiological effects are lethal to the bacterium. Polymyxins are selective for Gramnegative bacteria that have a hydrophobic outer membrane. Notes to Editor About Taj Pharma India Taj Pharmaceuticals Limited is known as a pharmaceuticals manufacturing company found and based in India. The company manufacturer's pharmaceuticals formulations and API for India and other countries. The company was established in 1995 as an enterprise and in 2004 became a public limited company. As per Mumbai pharmaxil and Chemixil association the company manufacturers and exports to countries like Iran, Iraq and Asia Pacific. In recent EU-Indonesia Business Dialogue (EIBD) conference Taj Pharma Group was listed amongst top 10 pharmaceutical companies in EU by 2008 sales. The Group sales 16,234 ($M) making the company 12 ranked in EU by 2008 sales. Founded as a company for finished formulation marketing and Export and then entered Api and Agro business in 2004 and 2007 respectively. About Network18 Network18 Media & Investments Limited (BSE: 532798, NSE: Network18) is an Indian media conglomerate with interests in television, print, internet, film, mobile content and allied businesses. Network 18 FinCap is the holding company for several media entities in India such as Television Eighteen India Ltd (TV18), IBN 18 Broadcast Ltd, Web 18, Studio 18,Shop 18,Infomedia 18 and Viacom 18. Raghav Bahl holds 51% shares of Network 18 Group. The group includes Network18, TV18, ibn18 and Infomedia18, all of which are listed in India on NSE & BSE. The company is owned by Raghav Bahl who has 51% stake in Network 18. For more information, please contact: Vandana Malik Executive Director page 1 / 2
  2. 2. (L) +91-22-6666 7777, (F) +91-22-2496 8238 © copyright 2016 India PRwire (http://www.indiaprwire.com) India PRwire disclaims any content contained in press release. Use of our service is governed by our privacy policy and terms of service. page 2 / 2

×